Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Epidiolex Pilot Trial for Presymptomatic Treatment of Sturge-Weber Syndrome
NCT07778810Phase 2Recruiting
- Sponsor
- Johns Hopkins University
- Start
- Sep 2026
- Primary completion
- Jul 2028
- Countries
- 1
01
Overview
A Phase 2 trial of cannabidiol in Sturge-Weber syndrome (SWS), sponsored by Johns Hopkins University. Started Sep 2026; status: recruiting.
02
Drugs
cannabidiol
03
Conditions
Sturge-Weber syndrome (SWS)
Beyond the preview
Go deeper on NCT07778810.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07778810.